|
CN105534490A
|
|
Control method of shiatsu type pulse-taking instrument
|
|
CN105596360A
|
|
Prunella vulgaris homogeneous polysaccharide as well as preparation method and application thereof
|
|
CN105646420A
|
|
Dehydrogenation zaluzanin C derivative and preparation method and application thereof
|
|
CN105640937A
|
|
Application of dehydrogenation zaluzanin C
|
|
CN105543351A
|
|
Application of miR-30c-5p to preparation of drug-induced liver injury biomarker
|
|
CN105541858A
|
|
Xanthone compositions, and preparation method, compositions and application thereof
|
|
CN105434458A
|
|
Medical new application of mirabilite
|
|
CN105687647A
|
|
New use of Qing'e pill in depression and anxiety prevention
|
|
CN105641363A
|
|
Antidepressant and anxiolytic use of Qing'e prescription extract
|
|
CN105671125A
|
|
Screening method of tyrosinase inhibitor or accelerant
|
|
CN105641320A
|
|
Traditional Chinese medicine concentrated pills
|
|
CN105617539A
|
|
Infrared physiotherapy suspended moxibustion instrument
|
|
CN105582029A
|
|
Brucea javanica oil floating type gastric retention microsphere and preparation method thereof
|
|
CN105572274A
|
|
Method for quantitative detection of 1,3-dihydroxy-2-hydroxymethyl anthraquinone content
|
|
CN105477646A
|
|
Method and kit for identifying types of drug acute allergies
|
|
CN105456280A
|
|
Compound targeted to actin binding protein Transgelin-2 and new application thereof
|
|
CN105440047A
|
|
Xanthone compound and preparation method and pharmaceutical composition and use thereof
|
|
CN105434421A
|
|
Griffipavixanthone medical application
|
|
CN1608660A
|
|
Compound medicine prepn for treating diabetes and its prepn process
|
